Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women

This study has been completed.
Centre Hospitalier Universitaire Vaudois
Swiss HIV Cohort Study
Information provided by (Responsible Party):
Marie Schneider, Policlinique Médicale Universitaire Identifier:
First received: May 31, 2012
Last updated: December 21, 2015
Last verified: December 2015
The purpose of this study is to compare adherence to antiretroviral therapy during pregnancy and postpartum, and to record adherence barriers and facilitators.

HIV Infection

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Retrospective Study: Evaluation of Antiretroviral Adherence During Pregnancy and Postpartum Using Electronic Monitoring Data

Resource links provided by NLM:

Further study details as provided by Policlinique Médicale Universitaire:

Primary Outcome Measures:
  • Change in patient adherence during pregnancy and postpartum [ Time Frame: before delivery (1 to 9 month) and postpartum (6 month) ]
    By electronic drug monitoring, pill count and subject interviews' marks

Secondary Outcome Measures:
  • Adherence barriers and facilitators [ Time Frame: pregnancy and postpartum (6 months) ]
    Data recorded in subject's interview marks

Estimated Enrollment: 26
Study Start Date: March 2012
Study Completion Date: September 2012
Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Detailed Description:
Data of all consecutive pregnant women included in the adherence enhancing program of the Pharmacy, Department of ambulatory care & community medicine, are collected. In this program, adherence is measured and enhanced by electronic monitoring, pill count, motivational interviewing and interdisciplinary collaboration. Electronic monitoring data are collected during pregnancy and postpartum, and compared. Barriers and facilitators are collected using interview's marks.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Pregnant and Postpartum Women enrolledin the HIV adherence program at the pharmacy of Department of Ambulatory Care and Community Medicine in Lausanne

Inclusion Criteria:

  • Pregnant Women
  • HIV-positive
  • Antiretroviral medication delivered in electronical monitors

Exclusion Criteria:

  • Monitored period during pregnancy < 1 month
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01621347

Policlinique Médicale Universitaire
Lausanne, Vaud, Switzerland, 1011
Sponsors and Collaborators
Policlinique Médicale Universitaire
Centre Hospitalier Universitaire Vaudois
Swiss HIV Cohort Study
Study Chair: Marie-Paule Schneider, PhD Policlinique Médicale Universitaire
Principal Investigator: Aurélie Gertsch, PhD-Student Policlinique Médicale Universitaire
Study Chair: Olivier Bugnon, Professor Policlinique Médicale Universitaire
Principal Investigator: Odile Michel, Student Policlinique Médicale Universitaire
Study Chair: Matthias Cavassini, M.D Centre Hosppitalier Universitaire Vaudois
  More Information

Responsible Party: Marie Schneider, Pharmacist, PhD, Policlinique Médicale Universitaire Identifier: NCT01621347     History of Changes
Other Study ID Numbers: 48/12
Study First Received: May 31, 2012
Last Updated: December 21, 2015

Keywords provided by Policlinique Médicale Universitaire:
Medication Adherence

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases processed this record on May 24, 2017